Stock Events

Stock Events

ARK Genomic Revolution 

$30.71
0
+$0.83+2.78% Today

Statistics

Day High
30.8
Day Low
30.41
52W High
-
52W Low
-
Volume
18,127
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Dec 21
$0.38
Dec 20
$0.79
Dec 19
$1.05
Dec 18
$0.2
Dec 18
$0.27
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ARKG.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Global X Genomics & Biotechnology
GNOM
Mkt Cap0
Global X Genomics & Biotechnology ETF, focuses on companies in genomics, making it a direct competitor to ARKG's thematic investment in genomics and biotech.
iShares Genomics Immunology and Healthcare
IDNA
Mkt Cap0
iShares Genomics Immunology and Healthcare ETF, targets similar genomics and immunology sectors, directly competing with ARKG's investment focus.
Invesco Biotechnology & Genome
PBE
Mkt Cap0
Invesco Dynamic Biotechnology & Genome ETF, focuses on biotech and genomic companies, making it a competitor by targeting similar investment themes.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF, while broader in biotech, it includes genomic companies, positioning it as a competitor to ARKG.
State Street SPDR S&P Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF, offers broad exposure to biotech, including genomics, competing with ARKG on the thematic investment front.
iShares Biotechnology
IBB
Mkt Cap0
iShares Nasdaq Biotechnology ETF, a broad biotech ETF that includes genomic companies, making it a competitor in the space.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap0
First Trust NYSE Arca Biotechnology Index Fund, although broader, it competes by investing in some of the same genomic and biotech companies as ARKG.
ALPS Medical Breakthroughs
SBIO
Mkt Cap0
ALPS Medical Breakthroughs ETF, focuses on medical breakthroughs, including genomics, positioning it as a thematic competitor.
Virtus LifeSci Biotech Clinical Trials
BBC
Mkt Cap0
Virtus LifeSci Biotech Clinical Trials ETF, focuses on biotech companies in clinical trials, including genomics, making it a niche competitor.

About

The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
Show more...
CEO
Country
US
ISIN
US00214Q3020

Listings

LSE
GB
0CQL.LSE
BATS
US
ARKG
BOATS
BOATS
ARKG.BOATS

0 Comments

Share your thoughts

FAQ

What is ARK Genomic Revolution stock price today?▼
The current price of ARKG.BOATS is $30.71 USD — it has increased by +2.78% in the past 24 hours. Watch ARK Genomic Revolution stock price performance more closely on the chart.
What is ARK Genomic Revolution stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ARK Genomic Revolution stocks are traded under the ticker ARKG.BOATS.
Does ARK Genomic Revolution pay dividends?▼
Yes, ARKG.BOATS dividends are paid annual. The last dividend per share was 0.38 USD. As of today, Dividend Yield (FWD)% is 0%.
When did ARK Genomic Revolution complete a stock split?▼
ARK Genomic Revolution has not had any recent stock splits.